Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 384.0 | 67 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 169.5 | 62 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 157.0 | 55 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 1232.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 436.5 | 66 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 206.0 | 50 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 206.0 | 71 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 156.0 | 67 | |
N2759 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 188.0 | 67 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 197.5 | 56 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 207.0 | 61 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 173.5 | 60 | |
N2586 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 163.0 | 55 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 53.0 | 62 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 51.5 | 52 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 47.0 | 58 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 58.0 | 59 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 44.5 | 68 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 57.5 | 54 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 43.0 | 46 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 52.0 | 67 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 113.0 | 73 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 119.0 | 57 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 93.0 | 71 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 107.0 | 52 |